竹绵汤配方颗粒联合艾司佐匹克隆治疗睡眠质量差的疗效:一项多中心、随机对照、优效性试验。

Wang Yichen, W U Shiyi, Wang Zhengyan, Chang Wenling, Xie Zhihao, Tang Xing, Zhao Songmei, Zhou Jing, Chen Zehong, Wang Chao, Yang Chunxia
{"title":"竹绵汤配方颗粒联合艾司佐匹克隆治疗睡眠质量差的疗效:一项多中心、随机对照、优效性试验。","authors":"Wang Yichen, W U Shiyi, Wang Zhengyan, Chang Wenling, Xie Zhihao, Tang Xing, Zhao Songmei, Zhou Jing, Chen Zehong, Wang Chao, Yang Chunxia","doi":"10.19852/j.cnki.jtcm.2024.01.002","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the efficacy and safety of Zhumian Tang formula granules combined with eszopiclone for treating poor sleep quality.</p><p><strong>Methods: </strong>This multi-center, dynamic block-randomized, parallel-group superiority clinical trial included 130 patients. The combined treatment group received Zhumian Tang formula granules combined with eszopiclone treatment, and the control group received eszopiclone treatment only. The group allocation ratio was 1∶1. The duration of treatment was 2 weeks. Participants were asked to complete questionnaires before treatment, after 1 week of the intervention, after 2 weeks of the intervention, and at the follow-up on week 3. The primary outcomes were the Pittsburgh Sleep Quality Index (PSQI) score and the total effective rate of treatment. The secondary outcome was the rate of adverse effects.</p><p><strong>Results: </strong>Compared with the eszopiclone treatment group, the PSQI score of the combined treatment group was significantly lower after 2 weeks of the intervention (6.98 <i>vs</i> 8.26, <i>P <</i> 0.05). However, there was no significant difference in the mean PSQI score after 1 week of the intervention (9.89 <i>vs</i> 9.15, <i>P =</i> 0.124). After the follow-up on week 3, the PSQI score of the combined treatment group remained significantly lower than that of the eszopiclone treatment group (6.12 <i>vs</i> 8.31, <i>P <</i> 0.001). The total effective rates of treatment of the combined group and the eszopiclone group were 36.92% <i>vs</i> 35.38% (<i>Z =</i> 0.033, <i>P =</i> 0.855) after 1 week of the intervention, 83.08% <i>vs</i> 58.46% (<i>Z =</i> 9.519, <i>P <</i> 0.05) after 2 weeks of the intervention, and 83.08% <i>vs</i> 61.54% (<i>Z =</i> 7.530, <i>P <</i> 0.05) and after the follow-up on week 3, respectively. There was no significant difference in the overall rate of adverse reactions between the combined and eszopiclone treatment groups (21.53% <i>vs</i> 31.8%, <i>P =</i> 0.318).</p><p><strong>Conclusion: </strong>The combination of Zhumian Tang formula granules with eszopiclone was found to be safe and more effective in improving sleep quality than eszopiclone alone. Traditional Chinese medicine can enhance the effectiveness of Western medicine in the treatment of insomnia.</p>","PeriodicalId":94119,"journal":{"name":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774717/pdf/","citationCount":"0","resultStr":"{\"title\":\"Efficacy of Zhumian Tang formula granules combined with eszopiclone for the treatment of poor sleep quality: a multi-center, randomized controlled, superiority trial.\",\"authors\":\"Wang Yichen, W U Shiyi, Wang Zhengyan, Chang Wenling, Xie Zhihao, Tang Xing, Zhao Songmei, Zhou Jing, Chen Zehong, Wang Chao, Yang Chunxia\",\"doi\":\"10.19852/j.cnki.jtcm.2024.01.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To evaluate the efficacy and safety of Zhumian Tang formula granules combined with eszopiclone for treating poor sleep quality.</p><p><strong>Methods: </strong>This multi-center, dynamic block-randomized, parallel-group superiority clinical trial included 130 patients. The combined treatment group received Zhumian Tang formula granules combined with eszopiclone treatment, and the control group received eszopiclone treatment only. The group allocation ratio was 1∶1. The duration of treatment was 2 weeks. Participants were asked to complete questionnaires before treatment, after 1 week of the intervention, after 2 weeks of the intervention, and at the follow-up on week 3. The primary outcomes were the Pittsburgh Sleep Quality Index (PSQI) score and the total effective rate of treatment. The secondary outcome was the rate of adverse effects.</p><p><strong>Results: </strong>Compared with the eszopiclone treatment group, the PSQI score of the combined treatment group was significantly lower after 2 weeks of the intervention (6.98 <i>vs</i> 8.26, <i>P <</i> 0.05). However, there was no significant difference in the mean PSQI score after 1 week of the intervention (9.89 <i>vs</i> 9.15, <i>P =</i> 0.124). After the follow-up on week 3, the PSQI score of the combined treatment group remained significantly lower than that of the eszopiclone treatment group (6.12 <i>vs</i> 8.31, <i>P <</i> 0.001). The total effective rates of treatment of the combined group and the eszopiclone group were 36.92% <i>vs</i> 35.38% (<i>Z =</i> 0.033, <i>P =</i> 0.855) after 1 week of the intervention, 83.08% <i>vs</i> 58.46% (<i>Z =</i> 9.519, <i>P <</i> 0.05) after 2 weeks of the intervention, and 83.08% <i>vs</i> 61.54% (<i>Z =</i> 7.530, <i>P <</i> 0.05) and after the follow-up on week 3, respectively. There was no significant difference in the overall rate of adverse reactions between the combined and eszopiclone treatment groups (21.53% <i>vs</i> 31.8%, <i>P =</i> 0.318).</p><p><strong>Conclusion: </strong>The combination of Zhumian Tang formula granules with eszopiclone was found to be safe and more effective in improving sleep quality than eszopiclone alone. Traditional Chinese medicine can enhance the effectiveness of Western medicine in the treatment of insomnia.</p>\",\"PeriodicalId\":94119,\"journal\":{\"name\":\"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10774717/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.19852/j.cnki.jtcm.2024.01.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19852/j.cnki.jtcm.2024.01.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:评估竹绵汤配方颗粒联合艾司佐匹克隆治疗睡眠质量差的有效性和安全性:评估竹绵汤配方颗粒联合艾司佐匹克隆治疗睡眠质量差的疗效和安全性:这项多中心、动态整群随机、平行分组的优效临床试验包括 130 名患者。联合治疗组接受竹绵汤配方颗粒联合艾佐匹克隆治疗,对照组仅接受艾佐匹克隆治疗。组间分配比例为 1∶1。疗程为 2 周。受试者需在治疗前、干预一周后、干预两周后和第三周的随访中填写问卷。主要结果是匹兹堡睡眠质量指数(PSQI)得分和治疗总有效率。次要结果是不良反应率:与艾司佐匹克隆治疗组相比,联合治疗组的 PSQI 评分在干预 2 周后显著降低(6.98 vs 8.26,P 0.05)。然而,干预 1 周后,PSQI 平均得分没有明显差异(9.89 vs 9.15,P = 0.124)。第 3 周随访后,联合治疗组的 PSQI 得分仍明显低于艾佐匹克隆治疗组(6.12 vs 8.31,P 0.001)。干预1周后,联合治疗组和艾司佐匹克隆治疗组的治疗总有效率分别为36.92% vs 35.38% (Z = 0.033, P = 0.855);干预2周后,联合治疗组和艾司佐匹克隆治疗组的治疗总有效率分别为83.08% vs 58.46% (Z = 9.519, P 0.05);第3周随访后,联合治疗组和艾司佐匹克隆治疗组的治疗总有效率分别为83.08% vs 61.54% (Z = 7.530, P 0.05)。联合治疗组和艾司佐匹克隆治疗组的不良反应总发生率无明显差异(21.53% vs 31.8%,P = 0.318):结论:与单独使用埃佐匹克隆相比,竹绵汤配方颗粒与埃佐匹克隆联合用药在改善睡眠质量方面安全有效。中药可提高西药治疗失眠症的疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Efficacy of Zhumian Tang formula granules combined with eszopiclone for the treatment of poor sleep quality: a multi-center, randomized controlled, superiority trial.

Objective: To evaluate the efficacy and safety of Zhumian Tang formula granules combined with eszopiclone for treating poor sleep quality.

Methods: This multi-center, dynamic block-randomized, parallel-group superiority clinical trial included 130 patients. The combined treatment group received Zhumian Tang formula granules combined with eszopiclone treatment, and the control group received eszopiclone treatment only. The group allocation ratio was 1∶1. The duration of treatment was 2 weeks. Participants were asked to complete questionnaires before treatment, after 1 week of the intervention, after 2 weeks of the intervention, and at the follow-up on week 3. The primary outcomes were the Pittsburgh Sleep Quality Index (PSQI) score and the total effective rate of treatment. The secondary outcome was the rate of adverse effects.

Results: Compared with the eszopiclone treatment group, the PSQI score of the combined treatment group was significantly lower after 2 weeks of the intervention (6.98 vs 8.26, P < 0.05). However, there was no significant difference in the mean PSQI score after 1 week of the intervention (9.89 vs 9.15, P = 0.124). After the follow-up on week 3, the PSQI score of the combined treatment group remained significantly lower than that of the eszopiclone treatment group (6.12 vs 8.31, P < 0.001). The total effective rates of treatment of the combined group and the eszopiclone group were 36.92% vs 35.38% (Z = 0.033, P = 0.855) after 1 week of the intervention, 83.08% vs 58.46% (Z = 9.519, P < 0.05) after 2 weeks of the intervention, and 83.08% vs 61.54% (Z = 7.530, P < 0.05) and after the follow-up on week 3, respectively. There was no significant difference in the overall rate of adverse reactions between the combined and eszopiclone treatment groups (21.53% vs 31.8%, P = 0.318).

Conclusion: The combination of Zhumian Tang formula granules with eszopiclone was found to be safe and more effective in improving sleep quality than eszopiclone alone. Traditional Chinese medicine can enhance the effectiveness of Western medicine in the treatment of insomnia.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Assessment of phytochemicals, antioxidant, anti-hemolytic, anti-inflammatory and anti-cancer potential of flowers, leaves and stem extracts of. Study on the effect and mechanism of Yanghe decoction Huacai on tissue repair ofsyndrome after anal fistula surgery. Effect of moxibustion on expression profile of miRNAs in Tripterygium glycoside-induced decreased ovarian reserve. Effect on serum metabolomics of rats with premature ovarian insufficiency by Zhibian (BL54) through Shuidao (ST28) acupuncture. Electroacupuncture ameliorates blood-brain barrier disruption after ischemic stroke through histone acetylation regulation at the matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 2 genes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1